Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Limitations of resting haemodynamics in chronic thromboembolic disease without pulmonary hypertension.

Swietlik EM, Ruggiero A, Fletcher AJ, Taboada D, Knightbridge E, Harlow L, Harvey I, Screaton N, Cannon JE, Sheares KKK, Ng C, Jenkins DP, Pepke-Zaba J, Toshner MR.

Eur Respir J. 2018 Nov 8. pii: 1801787. doi: 10.1183/13993003.01787-2018. [Epub ahead of print] No abstract available.

PMID:
30409818
2.

The outcome of reoperative pulmonary endarterectomy surgery.

Ali JM, Dunning J, Ng C, Tsui S, Cannon JE, Sheares KK, Taboada D, Toshner M, Screaton N, Pepke-Zaba J, Jenkins DP.

Interact Cardiovasc Thorac Surg. 2018 Jun 1;26(6):932-937. doi: 10.1093/icvts/ivx424.

PMID:
29373658
3.

Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.

Sithamparanathan S, Nair A, Thirugnanasothy L, Coghlan JG, Condliffe R, Dimopoulos K, Elliot CA, Fisher AJ, Gaine S, Gibbs JSR, Gatzoulis MA, E Handler C, Howard LS, Johnson M, Kiely DG, Lordan JL, Peacock AJ, Pepke-Zaba J, Schreiber BE, Sheares KKK, Wort SJ, Corris PA; National Pulmonary Hypertension Service Research Collaboration of the United Kingdom and Ireland.

J Heart Lung Transplant. 2017 Jul;36(7):770-779. doi: 10.1016/j.healun.2016.12.014. Epub 2016 Dec 31.

PMID:
28190786
4.

Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.

Charalampopoulos A, Gibbs JS, Davies RJ, Gin-Sing W, Murphy K, Sheares KK, Pepke-Zaba J, Jenkins DP, Howard LS.

J Appl Physiol (1985). 2016 Sep 1;121(3):623-8. doi: 10.1152/japplphysiol.00087.2016. Epub 2016 Jul 14.

5.

Endothelin ETA receptors predominate in chronic thromboembolic pulmonary hypertension.

Southwood M, MacKenzie Ross RV, Kuc RE, Hagan G, Sheares KK, Jenkins DP, Goddard M, Davenport AP, Pepke-Zaba J.

Life Sci. 2016 Aug 15;159:104-110. doi: 10.1016/j.lfs.2016.02.036. Epub 2016 Feb 10.

6.

Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease.

Taboada D, Pepke-Zaba J, Jenkins DP, Berman M, Treacy CM, Cannon JE, Toshner M, Dunning JJ, Ng C, Tsui SS, Sheares KK.

Eur Respir J. 2014 Dec;44(6):1635-45. doi: 10.1183/09031936.00050114. Epub 2014 Sep 18.

7.

Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.

Ling Y, Johnson MK, Kiely DG, Condliffe R, Elliot CA, Gibbs JS, Howard LS, Pepke-Zaba J, Sheares KK, Corris PA, Fisher AJ, Lordan JL, Gaine S, Coghlan JG, Wort SJ, Gatzoulis MA, Peacock AJ.

Am J Respir Crit Care Med. 2012 Oct 15;186(8):790-6. doi: 10.1164/rccm.201203-0383OC. Epub 2012 Jul 12.

PMID:
22798320
8.

Predicting survival in pulmonary arterial hypertension in the UK.

Lee WT, Ling Y, Sheares KK, Pepke-Zaba J, Peacock AJ, Johnson MK.

Eur Respir J. 2012 Sep;40(3):604-11. doi: 10.1183/09031936.00196611. Epub 2012 May 3.

9.

Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH.

Toshner M, Suntharalingam J, Fesler P, Soon E, Sheares KK, Jenkins D, White P, Morrell NW, Naeije R, Pepke-Zaba J.

Eur Respir J. 2012 Sep;40(3):612-7. doi: 10.1183/09031936.00134111. Epub 2012 Feb 23.

10.

How do I manage a patient with suspected acute pulmonary embolism?

Sheares KK.

Clin Med (Lond). 2011 Apr;11(2):156-9. Review.

PMID:
21526699
11.

Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension.

Soon E, Treacy CM, Toshner MR, MacKenzie-Ross R, Manglam V, Busbridge M, Sinclair-McGarvie M, Arnold J, Sheares KK, Morrell NW, Pepke-Zaba J.

Thorax. 2011 Apr;66(4):326-32. doi: 10.1136/thx.2010.147272. Epub 2011 Feb 5.

PMID:
21297151
12.

Survival after pulmonary thromboendarterectomy: effect of residual pulmonary hypertension.

Freed DH, Thomson BM, Berman M, Tsui SS, Dunning J, Sheares KK, Pepke-Zaba J, Jenkins DP.

J Thorac Cardiovasc Surg. 2011 Feb;141(2):383-7. doi: 10.1016/j.jtcvs.2009.12.056. Epub 2010 May 13.

13.

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension.

Toshner MR, Gopalan D, Suntharalingam J, Treacy C, Soon E, Sheares KK, Morrell NW, Screaton N, Pepke-Zaba J.

J Heart Lung Transplant. 2010 Jun;29(6):610-5. doi: 10.1016/j.healun.2009.12.014. Epub 2010 Mar 15.

14.

Functional and haemodynamic outcome 1 year after pulmonary thromboendarterectomy.

Freed DH, Thomson BM, Tsui SS, Dunning JJ, Sheares KK, Pepke-Zaba J, Jenkins DP.

Eur J Cardiothorac Surg. 2008 Sep;34(3):525-9; discussion 529-30. doi: 10.1016/j.ejcts.2008.04.018. Epub 2008 May 22.

PMID:
18501623
15.

Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension.

Suntharalingam J, Treacy CM, Doughty NJ, Goldsmith K, Soon E, Toshner MR, Sheares KK, Hughes R, Morrell NW, Pepke-Zaba J.

Chest. 2008 Aug;134(2):229-236. doi: 10.1378/chest.07-2681. Epub 2008 Feb 8.

PMID:
18263674
16.

Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension.

Suntharalingam J, Goldsmith K, Toshner M, Doughty N, Sheares KK, Hughes R, Jenkins D, Pepke-Zaba J.

Respir Med. 2007 Nov;101(11):2254-62. Epub 2007 Aug 13.

17.

Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).

Suntharalingam J, Hughes RJ, Goldsmith K, Doughty N, George P, Toshner M, Sheares KK, Pepke-Zaba J.

Vascul Pharmacol. 2007 Jun;46(6):449-55. Epub 2007 Feb 12.

PMID:
17368113
18.

Demographic features, BMPR2 status and outcomes in distal chronic thromboembolic pulmonary hypertension.

Suntharalingam J, Machado RD, Sharples LD, Toshner MR, Sheares KK, Hughes RJ, Jenkins DP, Trembath RC, Morrell NW, Pepke-Zaba J.

Thorax. 2007 Jul;62(7):617-22. Epub 2007 Feb 7.

19.

Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells.

Sheares KK, Jeffery TK, Long L, Yang X, Morrell NW.

Am J Physiol Lung Cell Mol Physiol. 2004 Nov;287(5):L919-27. Epub 2004 Jun 25.

20.

New insights into oxygen sensing at a cellular level.

Walmsley SR, Sheares KK, Sobolewski A, Morrell NW, Chilvers ER.

Thorax. 2004 Feb;59(2):90-2. No abstract available.

21.

Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells.

Yang X, Sheares KK, Davie N, Upton PD, Taylor GW, Horsley J, Wharton J, Morrell NW.

Am J Respir Cell Mol Biol. 2002 Dec;27(6):688-96.

PMID:
12444028
22.

Supplemental Content

Loading ...
Support Center